I think not stockrock..He was asked a question and got caught out a little so said , in the short term.....and here is a bit more .."..We view a licensing deal for MPC-06-ID in the current or next quarter as almost a certainty."....and ....... Partnering discussions for this product appear to be very advanced. The primary hold-up has been that potential licensees wanted clarity regarding the remainder of the development plan for the product, as per the company. Mesoblast has since received written advice from the FDA on the topic and has incorporated that advice into the MPC-06-ID development plan. It is expected that these actions have provided the clarity potential licensees are seeking......lets wait and see......V
Some are positive !!, page-31
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |